MedPath

Clinical Performance of a New Daily Disposable Contact Lens Worn in an Established Contact Lens Wearing Population

Not Applicable
Completed
Conditions
Myopia
Refractive Error
Interventions
Device: Habitual Silicone Hydrogel Contact Lens
Device: narafilcon A
Registration Number
NCT00708643
Lead Sponsor
Johnson & Johnson Vision Care, Inc.
Brief Summary

This study seeks to evaluate the clinical and subjective performance of a new daily disposable soft contact lens.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  1. They are of legal age (17 years) and capacity to volunteer.
  2. They understand their rights as a research subject and are willing to sign a Statement of Informed Consent.
  3. They are willing and able to follow the protocol.
  4. They would be expected to attain at least 6/9 (20/30) in each eye with the study lenses.
  5. They are able to wear contact lenses with a back vertex power of -1.00 to -6.00DS.
  6. They have a maximum of 1.00D of refractive astigmatism (i.e. ≤ 1.00 DC).
  7. They have successfully worn contact lenses within six months of starting the study.
Exclusion Criteria
  1. They have an ocular disorder which would normally contra-indicate contact lens wear.
  2. They have a systemic disorder which would normally contra-indicate contact lens wear.
  3. They are using any topical medication such as eye drops or ointment.
  4. They are aphakic.
  5. They have had corneal refractive surgery.
  6. They have any corneal distortion resulting from previous hard or rigid lens wear or has keratoconus.
  7. They are pregnant or lactating.
  8. They have grade 2 or greater of any of the following ocular surface signs: corneal oedema, corneal vascularisation, corneal staining, tarsal conjunctival changes or any other abnormality which would normally contraindicate contact lens wear.
  9. They have any infectious disease (e.g. hepatitis) or any immunosuppressive disease (e.g. HIV).
  10. They have diabetes.
  11. They have taken part in any other clinical trial or research, within two weeks prior to starting this study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Habitual silicone hydrogelHabitual Silicone Hydrogel Contact LensHabitual contact lens wear.
narafilcon Anarafilcon ASilicone hydrogel daily disposable contact lens
Primary Outcome Measures
NameTimeMethod
Upper Lid Margin StainingAt 2 weeks and 4 weeks.

Measures the trauma to tissue that lines the margin of the inside of the upper eyelid on a 0 to 3 scale, with 0=none to 3=severe. The analysis is the average grade over all time frames.

Limbal HyperemiaAt 2 weeks and 4 weeks

Measures the redness of the limbal region of the eye on a scale of 0 to 100 grade with 0=none and 100=severe. The analysis is the average grade over all time frames.

Lens ComfortAt 3,7,10,13,17,21,24, and 27 days

Rating of lens comfort by rating agreement to the following statement:

"The lenses I am wearing are comfortable."

Rating using the following scale:

1=strongly agree, 2=agree, 3=neutral, 4=disagree, 5=strongly disagree. The rating is averaged over all time frames.

Secondary Outcome Measures
NameTimeMethod
Corneal StainingAt 2 weeks and 4 weeks.

A measure of corneal abrasion using a 0 to 100 scale with 0=none, 25=micropunctate, 50=macropunctate, 75=coalescence, 100=patch. The analysis is the average grade over all time frames.

Tarsal HyperemiaAt 2 weeks and 4 weeks.

Measures the amount of redness to the tissue of the inside upper and lower eyelid using a 0 to 100 scale with 0=none and 100=severe.

Tarsal RoughnessAt 2 weeks and 4 weeks

Measures the amount of roughness to the tissue of the inside upper and lower eyelid on a scale of 0 to 100 with 0=none and 100=severe. The analysis is the average grade over all time frames.

Trial Locations

Locations (1)

Centre for Contact Lens Research

🇨🇦

Waterloo, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath